Picture of Thalia Therapeutics logo

THAT — Thalia Therapeutics News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: N4 Pharma Announces Positive Results From In Vivo Study Of Nuvec

May 12 (Reuters) - N4 Pharma PLC N4P.L:

N4 PHARMA PLC: POSITIVE RESULTS FROM FIRST IN VIVO STUDY OF DUAL-LOADED NUVEC FOR IBD

Source text: ID:nRSL1308Ia

Further company coverage: N4P.L

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Thalia Therapeutics

See all news